Trademark: 98160589
Word
PROJECT GOLD
Status Date
Tuesday, September 10, 2024
Filing Date
Friday, September 1, 2023
Published for Opposition
Tuesday, September 10, 2024
40 Consulting services in the field of pharmaceutical manufacturing, namely, generic drugs for cancer treatment
35 Promoting the interests of cancer patients by means of public advocacy, specifically access and availability of generic drugs for cancer treatment; Promoting public awareness of supply chain issues of generic cancer treatment drugs by means of public advocacy; Pharmaceutical cost management services and drug utilization review services, namely, generic drugs for cancer treatment; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry, namely, the manufacture and distribution of generic cancer treatment drugs; Promoting public interest and awareness of availability and accessibility of generic drugs for cancer treatment; Consulting in the field of distributorship services for pharmaceuticals, namely, generic drugs for cancer treatment
45 Providing patient advocate services in the field of cancer treatment, namely, increasing access to and availability of generic drugs therefor; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication, specifically for generic drugs for cancer treatment; Providing information about legal eligibility requirements for government medical and pharmaceutical programs, namely, for access to and availability of generic drugs for cancer treatment
44 Pharmaceutical advice, namely, to facilitate and subsidize access to and availability of generic drugs for cancer treatment; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, namely, generic drugs for cancer treatment
Feb 7, 2024
Use Amendment Filed
Sep 5, 2023
New Application Entered
Sep 27, 2023
New Application Office Supplied Data Entered
Feb 6, 2024
Teas Amendment Of Use Received
Feb 7, 2024
Amendment To Use Processing Complete
May 3, 2024
Non-Final Action E-Mailed
May 3, 2024
Use Amendment Accepted
Apr 30, 2024
Assigned To Examiner
May 3, 2024
Notification Of Non-Final Action E-Mailed
May 3, 2024
Non-Final Action Written
Aug 5, 2024
Teas/Email Correspondence Entered
Aug 5, 2024
Teas Response To Office Action Received
Aug 6, 2024
Examiner's Amendment Entered
Aug 6, 2024
Examiners Amendment E-Mailed
Aug 6, 2024
Examiners Amendment -Written
Aug 6, 2024
Notification Of Examiners Amendment E-Mailed
Aug 6, 2024
Approved For Pub - Principal Register
May 4, 2024
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Aug 5, 2024
Correspondence Received In Law Office
Aug 21, 2024
Notification Of Notice Of Publication E-Mailed
Sep 10, 2024
Published For Opposition
Sep 10, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
